Literature DB >> 21478161

The strictly conserved Arg-321 residue in the active site of Escherichia coli topoisomerase I plays a critical role in DNA rejoining.

Gagandeep Narula1, Thirunavukkarasu Annamalai, Sandra Aedo, Bokun Cheng, Elena Sorokin, Agnes Wong, Yuk-Ching Tse-Dinh.   

Abstract

The strictly conserved arginine residue proximal to the active site tyrosine of type IA topoisomerases is required for the relaxation of supercoiled DNA and was hypothesized to be required for positioning of the scissile phosphate for DNA cleavage to take place. Mutants of recombinant Yersinia pestis topoisomerase I with hydrophobic substitutions at this position were found in genetic screening to exhibit a dominant lethal phenotype, resulting in drastic loss in Escherichia coli viability when overexpressed. In depth biochemical analysis of E. coli topoisomerase I with the corresponding Arg-321 mutation showed that DNA cleavage can still take place in the absence of this arginine function if Mg(2+) is present to enhance the interaction of the enzyme with the scissile phosphate. However, DNA rejoining is inhibited in the absence of this conserved arginine, resulting in accumulation of the cleaved covalent intermediate and loss of relaxation activity. These new experimental results demonstrate that catalysis of DNA rejoining by type IA topoisomerases has a more stringent requirement than DNA cleavage. In addition to the divalent metal ions, the side chain of this arginine residue is required for the precise positioning of the phosphotyrosine linkage for nucleophilic attack by the 3'-OH end to result in DNA rejoining. Small molecules that can interfere or distort the enzyme-DNA interactions required for DNA rejoining by bacterial type IA topoisomerases could be developed into novel antibacterial drugs.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21478161      PMCID: PMC3099684          DOI: 10.1074/jbc.M111.229450

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  40 in total

1.  The acidic triad conserved in type IA DNA topoisomerases is required for binding of Mg(II) and subsequent conformational change.

Authors:  C X Zhu; Y C Tse-Dinh
Journal:  J Biol Chem       Date:  2000-02-25       Impact factor: 5.157

Review 2.  DNA topoisomerases and their poisoning by anticancer and antibacterial drugs.

Authors:  Yves Pommier; Elisabetta Leo; HongLiang Zhang; Christophe Marchand
Journal:  Chem Biol       Date:  2010-05-28

Review 3.  Targeting DNA topoisomerase II in cancer chemotherapy.

Authors:  John L Nitiss
Journal:  Nat Rev Cancer       Date:  2009-04-20       Impact factor: 60.716

4.  Crystal structure of a complex of a type IA DNA topoisomerase with a single-stranded DNA molecule.

Authors:  A Changela; R J DiGate; A Mondragón
Journal:  Nature       Date:  2001-06-28       Impact factor: 49.962

5.  A novel and unified two-metal mechanism for DNA cleavage by type II and IA topoisomerases.

Authors:  Bryan H Schmidt; Alex B Burgin; Joseph E Deweese; Neil Osheroff; James M Berger
Journal:  Nature       Date:  2010-06-03       Impact factor: 49.962

6.  The DNA relaxation activity and covalent complex accumulation of Mycobacterium tuberculosis topoisomerase I can be assayed in Escherichia coli: application for identification of potential FRET-dye labeling sites.

Authors:  Gagandeep Narula; Jennifer Becker; Bokun Cheng; Neil Dani; Maria V Abrenica; Yuk-Ching Tse-Dinh
Journal:  BMC Biochem       Date:  2010-09-30       Impact factor: 4.059

7.  Use of divalent metal ions in the dna cleavage reaction of human type II topoisomerases.

Authors:  Joseph E Deweese; Amber M Burch; Alex B Burgin; Neil Osheroff
Journal:  Biochemistry       Date:  2009-03-10       Impact factor: 3.162

8.  Asp-to-Asn substitution at the first position of the DxD TOPRIM motif of recombinant bacterial topoisomerase I is extremely lethal to E. coli.

Authors:  Bokun Cheng; Thirunavukkarasu Annamalai; Elena Sorokin; Maria Abrenica; Sandra Aedo; Yuk-Ching Tse-Dinh
Journal:  J Mol Biol       Date:  2008-11-05       Impact factor: 5.469

Review 9.  The DNA cleavage reaction of topoisomerase II: wolf in sheep's clothing.

Authors:  Joseph E Deweese; Neil Osheroff
Journal:  Nucleic Acids Res       Date:  2008-11-28       Impact factor: 16.971

Review 10.  Phylogenomics of DNA topoisomerases: their origin and putative roles in the emergence of modern organisms.

Authors:  Patrick Forterre; Danièle Gadelle
Journal:  Nucleic Acids Res       Date:  2009-02-09       Impact factor: 16.971

View more
  19 in total

Review 1.  Targeting bacterial topoisomerase I to meet the challenge of finding new antibiotics.

Authors:  Yuk-Ching Tse-Dinh
Journal:  Future Med Chem       Date:  2015       Impact factor: 3.808

2.  Synthesis, evaluation, and CoMFA study of fluoroquinophenoxazine derivatives as bacterial topoisomerase IA inhibitors.

Authors:  Xufen Yu; Mingming Zhang; Thirunavukkarasu Annamalai; Priyanka Bansod; Gagandeep Narula; Yuk-Ching Tse-Dinh; Dianqing Sun
Journal:  Eur J Med Chem       Date:  2016-09-18       Impact factor: 6.514

3.  Evidence for Inhibition of Topoisomerase 1A by Gold(III) Macrocycles and Chelates Targeting Mycobacterium tuberculosis and Mycobacterium abscessus.

Authors:  Rashmi Gupta; Carolina Rodrigues Felix; Matthew P Akerman; Kate J Akerman; Cathryn A Slabber; Wenjie Wang; Jessie Adams; Lindsey N Shaw; Yuk-Ching Tse-Dinh; Orde Q Munro; Kyle H Rohde
Journal:  Antimicrob Agents Chemother       Date:  2018-04-26       Impact factor: 5.191

4.  Covalent Complex of DNA and Bacterial Topoisomerase: Implications in Antibacterial Drug Development.

Authors:  Purushottam B Tiwari; Prem P Chapagain; Ahmed Seddek; Thirunavukkarasu Annamalai; Aykut Üren; Yuk-Ching Tse-Dinh
Journal:  ChemMedChem       Date:  2020-03-18       Impact factor: 3.466

5.  Small-Molecule Inhibitors Targeting Topoisomerase I as Novel Antituberculosis Agents.

Authors:  Shayna Sandhaus; Thirunavukkarasu Annamalai; Greg Welmaker; Richard A Houghten; Carlos Paz; Pamela K Garcia; Angelo Andres; Gagandeep Narula; Carolina Rodrigues Felix; Sandra Geden; Mandy Netherton; Rashmi Gupta; Kyle H Rohde; Marc A Giulianotti; Yuk-Ching Tse-Dinh
Journal:  Antimicrob Agents Chemother       Date:  2016-06-20       Impact factor: 5.191

6.  Mechanistic insights from structure of Mycobacterium smegmatis topoisomerase I with ssDNA bound to both N- and C-terminal domains.

Authors:  Nan Cao; Kemin Tan; Xiaobing Zuo; Thirunavukkarasu Annamalai; Yuk-Ching Tse-Dinh
Journal:  Nucleic Acids Res       Date:  2020-05-07       Impact factor: 16.971

7.  Synthesizing topological structures containing RNA.

Authors:  Di Liu; Yaming Shao; Gang Chen; Yuk-Ching Tse-Dinh; Joseph A Piccirilli; Yossi Weizmann
Journal:  Nat Commun       Date:  2017-03-31       Impact factor: 14.919

8.  Identification of anziaic acid, a lichen depside from Hypotrachyna sp., as a new topoisomerase poison inhibitor.

Authors:  Bokun Cheng; Shugeng Cao; Victor Vasquez; Thirunavukkarasu Annamalai; Giselle Tamayo-Castillo; Jon Clardy; Yuk-Ching Tse-Dinh
Journal:  PLoS One       Date:  2013-04-08       Impact factor: 3.240

9.  Residues of E. coli topoisomerase I conserved for interaction with a specific cytosine base to facilitate DNA cleavage.

Authors:  Gagandeep Narula; Yuk-Ching Tse-Dinh
Journal:  Nucleic Acids Res       Date:  2012-07-24       Impact factor: 16.971

10.  RNA topoisomerase is prevalent in all domains of life and associates with polyribosomes in animals.

Authors:  Muzammil Ahmad; Yutong Xue; Seung Kyu Lee; Jennifer L Martindale; Weiping Shen; Wen Li; Sige Zou; Maria Ciaramella; Hélène Debat; Marc Nadal; Fenfei Leng; Hongliang Zhang; Quan Wang; Grace Ee-Lu Siaw; Hengyao Niu; Yves Pommier; Myriam Gorospe; Tao-Shih Hsieh; Yuk-Ching Tse-Dinh; Dongyi Xu; Weidong Wang
Journal:  Nucleic Acids Res       Date:  2016-06-01       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.